tradingkey.logo
tradingkey.logo
Search

Vor Biopharma Inc

VOR
Add to Watchlist
21.150USD
-0.650-2.98%
Close 07-31 16:00ETQuotes delayed by 15 min
1.15BMarket Cap
LossP/E TTM

VOR Financials

See Vor Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Vor Biopharma Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-5.11/-0.78
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-70.50
-107.15%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-1861.68%-5.11
19454.33%84.89
-30116.29%-121.63
-61539.21%-251.24
42.52%-0.26
-13.31%-0.44
18.01%-0.40
8.86%-0.41
-5.53%-0.45
26.41%-0.39
---0.49
---0.45
---0.43
---0.53
---1.81
----
----
----
----
----
Net Profit
-575.94%-219.59M
5709.72%1.72B
-2848.89%-812.68M
-5552.75%-1.57B
-5.46%-32.49M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
-8.34%-30.80M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-31.00%-23.91M
-28.21%-23.79M
-17.90%-21.66M
-52.08%-22.74M
-2.35%-18.25M
-32.81%-18.55M
-106.52%-18.37M
Debt to assets ratio
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Operating profit
-5.61%-35.16M
-14.85%-35.96M
1.42%-28.11M
-844.67%-274.28M
-2.99%-33.29M
-11.33%-31.31M
19.26%-28.51M
9.76%-29.04M
-6.26%-32.33M
-13.75%-28.12M
-46.53%-35.32M
-47.64%-32.17M
-33.43%-30.42M
-35.07%-24.73M
-29.56%-24.10M
-18.56%-21.79M
-66.06%-22.80M
-16.87%-18.31M
-57.84%-18.60M
-128.61%-18.38M
Net Profit
-575.94%-219.59M
5709.72%1.72B
-2848.89%-812.68M
-5552.75%-1.57B
-5.46%-32.49M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
-8.34%-30.80M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-31.00%-23.91M
-28.21%-23.79M
-17.90%-21.66M
-52.08%-22.74M
-2.35%-18.25M
-32.81%-18.55M
-106.52%-18.37M
Current assets
672.25%500.78M
374.69%458.11M
156.31%172.49M
127.05%204.93M
-42.01%64.85M
-31.46%96.51M
-59.08%67.30M
-52.84%90.26M
-48.45%111.82M
-40.58%140.80M
15.21%164.44M
20.49%191.39M
13.98%216.90M
10.52%236.95M
-38.50%142.73M
-36.28%158.84M
-28.53%190.30M
336.60%214.40M
254.18%232.07M
233.18%249.26M
Total current liabilities
-3.89%16.08M
35.24%25.17M
31.33%18.84M
325.86%58.77M
26.60%16.73M
19.52%18.61M
-6.78%14.35M
8.52%13.80M
5.04%13.21M
18.70%15.57M
38.61%15.39M
3.71%12.72M
-30.68%12.58M
29.21%13.12M
20.54%11.10M
47.66%12.26M
110.23%18.14M
-0.53%10.15M
21.18%9.21M
110.44%8.30M
Total assets
363.58%506.75M
224.81%464.13M
51.94%176.24M
45.05%205.37M
-34.56%109.31M
-27.88%142.89M
-47.99%115.99M
-43.59%141.59M
-39.82%167.03M
-33.82%198.13M
8.07%223.02M
11.74%250.99M
18.47%277.53M
23.40%299.37M
-20.21%206.37M
-18.36%224.62M
-20.03%234.27M
219.58%242.59M
192.16%258.63M
186.05%275.14M
Total liabilities
1419.71%657.17M
1259.46%628.44M
5480.73%2.40B
3832.77%1.71B
-1.71%43.24M
-2.48%46.23M
-10.79%43.04M
-6.51%43.51M
-7.02%43.99M
-2.78%47.40M
1.27%48.24M
-6.25%46.54M
18.82%47.32M
85.21%48.76M
85.55%47.64M
98.29%49.64M
54.64%39.82M
-4.74%26.33M
1.36%25.68M
14.61%25.04M
Total equity
-327.68%-150.42M
-269.98%-164.31M
-3150.49%-2.23B
-1635.18%-1.51B
-46.30%66.07M
-35.87%96.66M
-58.26%72.95M
-52.03%98.08M
-46.56%123.03M
-39.86%150.72M
10.11%174.78M
16.85%204.45M
18.39%230.22M
15.88%250.61M
-31.86%158.73M
-30.04%174.97M
-27.22%194.45M
348.02%216.26M
268.64%232.96M
236.42%250.11M
Net operating income
-23.11%-38.25M
5.24%-22.80M
-130.46%-53.66M
-61.05%-35.18M
-1.97%-31.07M
-0.15%-24.06M
16.54%-23.29M
9.35%-21.85M
-25.54%-30.46M
-30.96%-24.03M
-47.59%-27.90M
3.57%-24.10M
-5.96%-24.27M
-4.32%-18.35M
-8.99%-18.90M
-50.87%-24.99M
-29.78%-22.90M
-28.99%-17.59M
-110.35%-17.34M
-98.91%-16.57M
Net investment
-114350.87%-263.24M
-67919.44%-48.97M
-617.65%-244.00K
-98.78%646.00K
-100.52%-230.00K
-100.70%-72.00K
-100.08%-34.00K
288.52%52.99M
576.72%43.97M
110.65%10.34M
219.13%40.54M
604.77%13.64M
192.10%6.50M
-1530.04%-97.04M
249.68%12.70M
96.45%-2.70M
-502.48%-7.05M
-303.05%-5.95M
-434.72%-8.49M
-13675.54%-76.04M
Net financing
12454.79%74.87M
477.64%307.80M
52458.54%21.55M
564825.81%175.06M
-731.25%-606.00K
213044.00%53.29M
-76.70%41.00K
-114.22%-31.00K
-96.19%96.00K
-99.98%25.00K
-95.68%176.00K
-63.91%218.00K
1159.50%2.52M
36467.10%112.26M
1927.36%4.08M
235.73%604.00K
-99.91%200.00K
567.39%307.00K
-61.79%201.00K
-100.69%-445.00K

FAQs

What are the current assets of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its current assets were 458.11M, with a year-on-year change of 374.69.

What are the total assets of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its total assets of Vor Biopharma Inc were 464.13M, with a year-on-year change of 224.81.

What are the total liabilities of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its total liabilities of Vor Biopharma Inc were 628.44M, with a year-on-year change of 1259.46.

What is the total equity of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its total equity of Vor Biopharma Inc was -164.31M, with a year-on-year change of -269.98.

What is the net operating income of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its net operating income of Vor Biopharma Inc was -341.94M, with a year-on-year change of -182.16.

What is the net investment of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its net investment of Vor Biopharma Inc was -48.80M, with a year-on-year change of -150.39.

What is the net financing of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its net financing of Vor Biopharma Inc was 503.81M, with a year-on-year change of 843.60.

What is the Earnings Per Share (EPS) of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -70.50, with a year-on-year change of -107.15.

What is the net income of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its net income was -695.98M, with a year-on-year change of -495.29.

What is the Return on Assets (ROA) of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -229.31, with a year-on-year change of -234.43.

What is the operating profit of Vor Biopharma Inc?

According to Vor Biopharma Inc's FY2025 earnings report, its operating profit was -341.94M, with a year-on-year change of -182.16.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.